Franchise Agreement for the Healthcare & Pharma industry

Why Healthcare & Pharma businesses need an industry-specific Franchise Agreement

Healthcare & Pharma operators in Thailand work under specialised regimes including พรบ.ยา พ.ศ. 2510, พรบ.สถานพยาบาล, PDPA (health data). Off-the-shelf Franchise Agreement templates available online do not cover these obligations, and tend to be interpreted against the party with weaker bargaining power once a dispute arises.

Based on NYC Legal's experience with 450+ Healthcare & Pharma clients, the recurring pain points are: FDA registration · Adverse event · Patent cliff. Our industry-specific Franchise Agreement build is engineered to neutralise these risks before signature, anchored to recent Thai-court precedent from the last 5 years.

Legal framework referenced

An enforceable Franchise Agreement must integrate Thai general law, sector-specific rules, and the international conventions Thailand has acceded to:

• Thailand Personal Data Protection Act 2019 (PDPA) — fines up to THB 5M + criminal liability • Thailand Trade Competition Act 2017 — bans exclusive dealing that restricts competition • CISG (Vienna Convention 1980) — international sale of goods (Thailand not a party but opt-in is valid) • Thailand Labour Protection Act 1998 (as amended 2019) — non-compete capped at 2 years / reasonable radius

Sector rules for Healthcare & Pharma: • พรบ.ยา พ.ศ. 2510 • พรบ.สถานพยาบาล • PDPA (health data) • Medical Device Act — every clause is mapped to the relevant statute so it stands up in court and at arbitration.

Signature clauses included by default

Our Healthcare & Pharma edition of the Franchise Agreement includes the following provisions that generic templates omit:

(1) GMP/PIC/S compliance · (2) Patient data confidentiality · (3) Adverse event reporting 24h · (4) Recall provisions · (5) IP carve-out

Each clause has been reviewed by counsel with direct Healthcare & Pharma sector experience and benchmarked against Fortune 500 / Magic Circle precedent, so foreign counterparties accept them and the chosen governing law will enforce them as drafted.

Common pitfalls checklist

Across 450+ Healthcare & Pharma contract reviews, the recurring defects that render a contract unenforceable or one-sided are:

1. Dispute Resolution clause does not specify arbitration language — meta-dispute risk · 2. No Data Protection clause aligned with Thailand PDPA 2019 — fines up to THB 5M per breach · 3. Payment terms omit default interest (Thai CCC §224 default is 5% p.a.) · 4. No Notice clause specifying official addresses and delivery method · 5. No Severability clause — one void provision can void the whole contract · 6. Defined Terms are incomplete — key words used before they are defined, creating conflicting interpretations · 7. Termination clause has no cure period — invites unlawful immediate termination · 8. Limitation of Liability does not separate direct / indirect / consequential damages

Every NYC Legal draft passes a 32-point Pre-Sign Audit Checklist before delivery, eliminating the issues above as a matter of standard procedure.

Counterparties and typical use cases

The Franchise Agreement for Healthcare & Pharma businesses is most commonly used in relationships with FDA Thailand (อย.), โรงพยาบาล/คลินิก, Distributor, CRO, Insurance. Each counterparty carries a different bargaining posture, so our attorneys calibrate position (buy-side, sell-side, or neutral) and protection level (heavy, balanced, light) to match your deal objectives.

Primary use cases in this sector: F&B · Retail. For cross-border enforceability we ship a bilingual Thai–English version together with Notary Public certification plus Apostille (126 Hague-party states) or Consular Legalisation chain (rest of the world), packaged as a single engagement.

Four pricing tracks

1) Standard — from THB 25,000 · first draft in 7–10 business days · 2 revision rounds · Witness signing on request.

2) Express (Rush) — from THB 37,500 · first draft in 24-48 hours · 3 revision rounds · for deals that must close fast.

3) Premium (Negotiation) — from THB 62,500 · 5-8 page legal memorandum · risk matrix · 2 rounds of term-sheet negotiation · 6-month post-signing compliance checklist · for deals above THB 10M.

4) Retainer (Annual) — from THB 200,000/year · unlimited Franchise Agreement drafting and review · 4-hour legal hotline SLA · for Healthcare & Pharma businesses closing 3+ deals per month.

Six-step workflow

1) Intake — deal context, position, counterparty, governing law, budget captured via a 12-field form (15 minutes).

2) Risk Assessment — sector-specific risk matrix for Healthcare & Pharma delivered within 24 hours.

3) Drafting — senior counsel drafts against the 32-point Pre-Sign Audit Checklist within 7–10 business days.

4) Revision — client review, optional 30-minute call, 2-3 in-scope rounds.

5) Execution — final Word + PDF + signing instructions.

6) Post-Sign — file vaulted for 12 months · free revisions on regulatory change · ongoing monitoring of statutes affecting your contract.

Why pick NYC Legal for Franchise Agreement in Healthcare & Pharma

Attorneys 12+ years · 6 Notary Publics · 3,000+ documents per year · Healthcare & Pharma, FDI, listed companies, SMEs — 450+ direct Healthcare & Pharma clients.

Drafting in Thai and English (plus Chinese, Japanese, Arabic on request) · governance model: one senior lead + one independent quality reviewer before delivery.

Quality Guarantee — if a contract is held void or unenforceable due to our error, we refund the legal fee in full · backed by Professional Indemnity Insurance.

Frequently asked questions